Becker's Healthcare March 28, 2024
Several major insurers will cover the weight-loss drug Wegovy for Medicare members with certain heart conditions, the Wall Street Journal reported March 28.
Elevance Health, Kaiser Permanente and CVS Health told the outlet they will cover Wegovy when used to reduce the risk of heart attack and stroke for Medicare members with cardiovascular conditions.
On March 8, the FDA approved Novo Nordisk’s Wegovy to be used for preventing cardiovascular events in adults with cardiovascular disease who are also obese or overweight. The approval opened the door to broader coverage of the drug in Medicare. Federal law currently prohibits Medicare from paying for drugs to be used for weight loss only.
CMS issued guidance that allowed Part D...
Today's Sponsors
Today's Sponsor